Published in Neuron on December 18, 2003
The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology (2010) 10.17
Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry (2007) 8.87
Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron (2008) 6.68
The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat Rev Neurosci (2011) 5.79
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) (2007) 4.73
Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci (2008) 4.60
The triadic model perspective for the study of adolescent motivated behavior. Brain Cogn (2014) 4.16
Is avoiding an aversive outcome rewarding? Neural substrates of avoidance learning in the human brain. PLoS Biol (2006) 3.80
Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron (2008) 3.23
Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci (2006) 3.17
Differential encoding of losses and gains in the human striatum. J Neurosci (2007) 3.16
Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron (2010) 3.11
The circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathology. Dev Psychopathol (2005) 2.64
From fear to safety and back: reversal of fear in the human brain. J Neurosci (2008) 2.63
Dynorphin, stress, and depression. Brain Res (2009) 2.45
Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One (2009) 2.37
Valence and salience contribute to nucleus accumbens activation. Neuroimage (2007) 2.35
Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci (2013) 2.24
Brain mediators of predictive cue effects on perceived pain. J Neurosci (2010) 2.20
Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev (2007) 2.20
Entering adolescence: resistance to peer influence, risky behavior, and neural changes in emotion reactivity. Neuron (2011) 2.18
The role of the striatum in aversive learning and aversive prediction errors. Philos Trans R Soc Lond B Biol Sci (2008) 2.17
How humans integrate the prospects of pain and reward during choice. J Neurosci (2009) 2.14
A developmental neurobiological model of motivated behavior: anatomy, connectivity and ontogeny of the triadic nodes. Neurosci Biobehav Rev (2008) 1.95
Dopamine, behavioral economics, and effort. Front Behav Neurosci (2009) 1.91
Neural correlates of self-distraction from anxiety and a process model of cognitive emotion regulation. J Cogn Neurosci (2006) 1.82
Human striatal activation reflects degree of stimulus saliency. Neuroimage (2005) 1.78
Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens. J Neurosci (2008) 1.76
Avoiding negative outcomes: tracking the mechanisms of avoidance learning in humans during fear conditioning. Front Behav Neurosci (2009) 1.57
Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Natl Acad Sci U S A (2007) 1.50
Serotonin selectively modulates reward value in human decision-making. J Neurosci (2012) 1.49
Dissociation of neural regions associated with anticipatory versus consummatory phases of incentive processing. Psychophysiology (2007) 1.47
Contributions of the striatum to learning, motivation, and performance: an associative account. Trends Cogn Sci (2012) 1.42
A systematic review of fMRI reward paradigms used in studies of adolescents vs. adults: the impact of task design and implications for understanding neurodevelopment. Neurosci Biobehav Rev (2013) 1.40
Cerebral blood flow in immediate and sustained anxiety. J Neurosci (2007) 1.38
Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. Neurosci Biobehav Rev (2011) 1.35
The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav (2012) 1.33
Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress. J Neurosci (2010) 1.32
Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear. Cereb Cortex (2011) 1.32
The bivalent side of the nucleus accumbens. Neuroimage (2008) 1.32
Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One (2010) 1.29
Neural systems underlying approach and avoidance in anxiety disorders. Dialogues Clin Neurosci (2010) 1.27
Pain imaging in health and disease--how far have we come? J Clin Invest (2010) 1.24
Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain (2006) 1.21
Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. Am J Psychiatry (2013) 1.13
Enhanced processing of threat stimuli under limited attentional resources. Cereb Cortex (2008) 1.12
Neural systems underlying aversive conditioning in humans with primary and secondary reinforcers. Front Neurosci (2011) 1.11
Fear of losing money? Aversive conditioning with secondary reinforcers. Soc Cogn Affect Neurosci (2006) 1.11
The emotional harbinger effect: poor context memory for cues that previously predicted something arousing. Emotion (2008) 1.09
Distribution and compartmental organization of GABAergic medium-sized spiny neurons in the mouse nucleus accumbens. Front Neural Circuits (2013) 1.09
Functional specialization within the striatum along both the dorsal/ventral and anterior/posterior axes during associative learning via reward and punishment. Learn Mem (2011) 1.07
Nucleus accumbens, thalamus and insula connectivity during incentive anticipation in typical adults and adolescents. Neuroimage (2012) 1.06
An imaging genetics approach to understanding social influence. Front Hum Neurosci (2012) 1.04
Neural activation in the "reward circuit" shows a nonlinear response to facial attractiveness. Soc Neurosci (2010) 1.03
A stable sparse fear memory trace in human amygdala. J Neurosci (2011) 1.03
Pains in Parkinson disease--many syndromes under one umbrella. Nat Rev Neurol (2012) 1.01
Identifying a network of brain regions involved in aversion-related processing: a cross-species translational investigation. Front Integr Neurosci (2011) 1.00
Dissociable responses to punishment in distinct striatal regions during reversal learning. Neuroimage (2010) 1.00
Aberrant Effective Connectivity in Schizophrenia Patients during Appetitive Conditioning. Front Hum Neurosci (2011) 0.98
Amygdala involvement in human avoidance, escape and approach behavior. Neuroimage (2010) 0.98
Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex (2013) 0.97
From bad to worse: striatal coding of the relative value of painful decisions. Front Neurosci (2010) 0.95
Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol (2009) 0.94
Nothing to fear? Neural systems supporting avoidance behavior in healthy youths. Neuroimage (2010) 0.94
The nucleus accumbens is involved in both the pursuit of social reward and the avoidance of social punishment. Neuropsychologia (2013) 0.94
Distinct midbrain and habenula pathways are involved in processing aversive events in humans. J Neurosci (2015) 0.94
Common brain activations for painful and non-painful aversive stimuli. BMC Neurosci (2012) 0.94
Integrating functional neuroimaging and human operant research: brain activation correlated with presentation of discriminative stimuli. J Exp Anal Behav (2005) 0.93
Brain Activations to Emotional Pictures are Differentially Associated with Valence and Arousal Ratings. Front Hum Neurosci (2010) 0.93
Avoidance-based human Pavlovian-to-instrumental transfer. Eur J Neurosci (2013) 0.93
Pervasive competition between threat and reward in the brain. Soc Cogn Affect Neurosci (2013) 0.93
Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry (2014) 0.93
Dopaminergic reward sensitivity can promote adolescent health: A new perspective on the mechanism of ventral striatum activation. Dev Cogn Neurosci (2015) 0.92
Executive function and error detection: The effect of motivation on cingulate and ventral striatum activity. Hum Brain Mapp (2010) 0.91
Time course of recovery showing initial prefrontal cortex changes at 16 weeks, extending to subcortical changes by 3 years in pediatric bipolar disorder. J Affect Disord (2013) 0.91
The influence of context valence in the neural coding of monetary outcomes. Neuroimage (2009) 0.89
Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research. J Geriatr Psychiatry Neurol (2012) 0.88
Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology (2010) 0.88
Decision Neuroscience: Neuroeconomics. Wiley Interdiscip Rev Cogn Sci (2010) 0.87
Atypical nucleus accumbens morphology in psychopathy: another limbic piece in the puzzle. Int J Law Psychiatry (2013) 0.86
Breathing-controlled electrical stimulation could modify the affective component of neuropathic pain after amputation: a case report. J Pain Res (2012) 0.86
Prefrontal Cortex, Emotion, and Approach/Withdrawal Motivation. Soc Personal Psychol Compass (2008) 0.86
Neuroimaging in anxiety disorders. J Neural Transm (Vienna) (2008) 0.86
It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Front Pharmacol (2014) 0.86
Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training. Eur J Neurosci (2012) 0.86
Prefrontal/accumbal catecholamine system processes high motivational salience. Front Behav Neurosci (2012) 0.85
Neural systems underlying motivated behavior in adolescence: implications for preventive medicine. Prev Med (2011) 0.85
Two sides of the same coin: learning via positive and negative reinforcers in the human striatum. Dev Cogn Neurosci (2011) 0.83
Modulation of pain, nociception, and analgesia by the brain reward center. Neuroscience (2016) 0.83
Alterations in prefrontal-limbic functional activation and connectivity in chronic stress-induced visceral hyperalgesia. PLoS One (2013) 0.83
Aversive event anticipation affects connectivity between the ventral striatum and the orbitofrontal cortex in an fMRI avoidance task. PLoS One (2013) 0.83
Fear across the senses: brain responses to music, vocalizations and facial expressions. Soc Cogn Affect Neurosci (2014) 0.82
Strain-dependent differences in corticolimbic processing of aversive or rewarding stimuli. Front Syst Neurosci (2015) 0.82
Motor preparatory activity in posterior parietal cortex is modulated by subjective absolute value. PLoS Biol (2010) 0.81
Resting state functional connectivity of the basal nucleus of Meynert in humans: in comparison to the ventral striatum and the effects of age. Neuroimage (2014) 0.81
Intrinsic network activity in tinnitus investigated using functional MRI. Hum Brain Mapp (2016) 0.80
Neural mechanisms of negative reinforcement in children and adolescents with autism spectrum disorders. J Neurodev Disord (2015) 0.80
DAT genotype modulates striatal processing and long-term memory for items associated with reward and punishment. Neuropsychologia (2013) 0.80
Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder. Neurosci Lett (2011) 0.80
Negative symptoms in schizophrenia are associated with aberrant striato-cortical connectivity in a rewarded perceptual decision-making task. Neuroimage Clin (2015) 0.79
Grand challenges in global mental health. Nature (2011) 8.40
Schizophrenia. Lancet (2009) 8.14
Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage (2002) 6.71
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat Rev Neurosci (2011) 5.02
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry (2012) 4.54
Age-related changes in brain activity across the adult lifespan. J Cogn Neurosci (2006) 2.68
Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci (2003) 2.63
Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry (2007) 2.53
A cortical network sensitive to stimulus salience in a neutral behavioral context across multiple sensory modalities. J Neurophysiol (2002) 2.41
The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry (2012) 2.34
Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery (2003) 2.21
Recollective qualities modulate hippocampal activation during autobiographical memory retrieval. Hippocampus (2004) 2.13
Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry (2003) 2.11
Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. Am J Psychiatry (2013) 2.06
A multivariate analysis of age-related differences in default mode and task-positive networks across multiple cognitive domains. Cereb Cortex (2009) 2.02
Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull (2008) 2.01
Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment? Pharmacogenomics (2013) 1.97
Elevation of prolactin levels by atypical antipsychotics. Am J Psychiatry (2002) 1.96
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med (2006) 1.88
Age-related differences in the functional connectivity of the hippocampus during memory encoding. Hippocampus (2003) 1.83
Blood oxygen level-dependent signal variability is more than just noise. J Neurosci (2010) 1.79
A dual role for prediction error in associative learning. Cereb Cortex (2008) 1.78
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry (2007) 1.72
Characterizing spatial and temporal features of autobiographical memory retrieval networks: a partial least squares approach. Neuroimage (2004) 1.72
Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration. J Clin Psychopharmacol (2008) 1.70
Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke (2008) 1.69
An automated method for the extraction of regional data from PET images. Psychiatry Res (2006) 1.67
Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic. J Clin Psychiatry (2003) 1.66
The importance of being variable. J Neurosci (2011) 1.65
Separate brain regions code for salience vs. valence during reward prediction in humans. Hum Brain Mapp (2007) 1.64
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg (2002) 1.60
A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations. J Med Internet Res (2013) 1.58
The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry (2012) 1.58
The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology (2007) 1.56
Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol Psychiatry (2012) 1.56
Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain (2010) 1.56
An empirical comparison of SPM preprocessing parameters to the analysis of fMRI data. Neuroimage (2002) 1.55
Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry (2013) 1.53
Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res (2005) 1.53
Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry (2002) 1.51
Visual-spatial ability and fMRI cortical activation in surgery residents. Am J Surg (2007) 1.51
Viewing artworks: contributions of cognitive control and perceptual facilitation to aesthetic experience. Brain Cogn (2009) 1.50
D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia. J Clin Psychopharmacol (2009) 1.48
Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology (2010) 1.47
"Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci (2007) 1.47
The functional neuroanatomy of episodic and semantic autobiographical remembering: a prospective functional MRI study. J Cogn Neurosci (2004) 1.45
Bilateral horizontal gaze palsy in presumed paraneoplastic brainstem encephalitis associated with a benign ovarian teratoma. J Neuroophthalmol (2004) 1.45
Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J Neurochem (2006) 1.42
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans. Hum Brain Mapp (2008) 1.40
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry (2002) 1.39
Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol Psychiatry (2007) 1.39
Task-related activity in prefrontal cortex and its relation to recognition memory performance in young and old adults. Neuropsychologia (2005) 1.38
Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res (2012) 1.38
First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology (2007) 1.38
Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiatry (2004) 1.37
Early face processing specificity: it's in the eyes! J Cogn Neurosci (2007) 1.36
Resting brains never rest: computational insights into potential cognitive architectures. Trends Neurosci (2013) 1.36
The Talairach coordinate of a point in the MNI space: how to interpret it. Neuroimage (2005) 1.36
A common functional brain network for autobiographical, episodic, and semantic memory retrieval. Neuroimage (2009) 1.36
Sensorimotor cortical plasticity during recovery following spinal cord injury: a longitudinal fMRI study. Neurorehabil Neural Repair (2007) 1.35
Selective reduction of blood flow to white matter during hypercapnia corresponds with leukoaraiosis. Stroke (2008) 1.31
Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry (2012) 1.31
BOLD-MRI cerebrovascular reactivity findings in cocaine-induced cerebral vasculitis. Nat Clin Pract Neurol (2008) 1.30
Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms. J Clin Psychiatry (2008) 1.30
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry (2012) 1.29
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol (2012) 1.29
Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. J Neurosci (2005) 1.29
Alterations of the brain reward system in antipsychotic naïve schizophrenia patients. Biol Psychiatry (2012) 1.28
Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry (2002) 1.27
Improving permutation test power for group analysis of spatially filtered MEG data. Neuroimage (2004) 1.26
Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain. J Cereb Blood Flow Metab (2006) 1.26
Integrating mobile-phone based assessment for psychosis into people's everyday lives and clinical care: a qualitative study. BMC Psychiatry (2013) 1.25
High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO. Biol Psychiatry (2005) 1.24
The modulation of BOLD variability between cognitive states varies by age and processing speed. Cereb Cortex (2012) 1.23
Moment-to-moment brain signal variability: a next frontier in human brain mapping? Neurosci Biobehav Rev (2013) 1.23
Time course of the antipsychotic effect and the underlying behavioral mechanisms. Neuropsychopharmacology (2006) 1.22
Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report. Can J Psychiatry (2006) 1.22
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Neuropsychopharmacology (2005) 1.21
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry (2004) 1.21
Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol (2011) 1.20
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. Am J Psychiatry (2004) 1.20
Increased stress-induced dopamine release in psychosis. Biol Psychiatry (2011) 1.20
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making. J Psychiatr Res (2013) 1.20
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol (2009) 1.19
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLoS Med (2012) 1.19
Brain noise is task dependent and region specific. J Neurophysiol (2010) 1.19